Physician profile

Allan E Mendell

Child & Adolescent Psychiatry · Nashua, NH

NPI 1598704025

$2,067.54

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $667.71 2021
Sunovion Pharmaceuticals INC. $285.79 2019
Allergan, INC. $231.80 2020
Vanda Pharmaceuticals INC. $204.28 2019-2020
Takeda Pharmaceuticals U.S.A., INC. $164.43 2019-2020
Janssen Pharmaceuticals, INC $89.99 2019
Otsuka America Pharmaceutical, INC. $66.65 2019-2020
Shire North American Group INC $53.10 2019
Tris Pharma INC $51.04 2019
Ironshore Pharmaceuticals INC. $49.07 2019
Neos Therapeutics, LP $41.17 2019
Jazz Pharmaceuticals INC. $37.05 2019-2020
Lundbeck LLC $33.33 2019
Neurocrine Biosciences, INC. $33.04 2019
Merck Sharp & Dohme LLC $29.94 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Arbor Pharmaceuticals, INC. $15.26 2019
Shionogi INC $13.89 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Allan E Mendell

$2,067.54

in general payments reported 2019-2025

Years
2019-2021
Top company
Abbvie INC.

https://glasscript.com/doctor/379866/allan-e-mendell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.